Crunch Fitness vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Budget gym franchise founded 1989; $638M revenue; 500+ locations; 3M+ members; non-judgmental philosophy; tiered memberships from $10/mo; Inc. 5000 fastest-growing company 2025
About
Crunch Fitness was founded in 1989 in New York City with a non-judgmental fitness philosophy emphasizing inclusivity and fun over performance-focused or intimidating gym atmospheres. The brand built its identity around group fitness classes, unusual workout formats, and a welcoming environment that attracted non-traditional gym-goers. Crunch transitioned to a franchise model, accelerating growth from its East Coast origins into a national and international footprint while maintaining core brand identity.\n\nCrunch operates a tiered membership model — Crunch Base, Peak, and One — with pricing from budget to mid-market and perks scaling accordingly. Club features include a broad group fitness class schedule (Zumba, cycling, HIIT, yoga, dance), strength and cardio equipment, tanning, and HydroMassage at select locations. The Crunch+ digital app provides on-demand and live-streamed workout content for engagement between physical visits. Franchise operators benefit from brand recognition, training programs, and centralized technology platforms.\n\nCrunch operates 400+ locations across the United States and internationally, making it one of the larger gym franchise systems in the country by location count. The brand occupies a differentiated position between premium studios (Equinox) and ultra-budget operators (Planet Fitness), offering group fitness breadth and club amenities at accessible price points. Crunch's franchise model provides a capital-light growth path with strong unit economics for franchisees in underserved mid-tier gym markets.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.